Australia markets closed

Progyny, Inc. (PGNY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
38.67+0.95 (+2.52%)
At close: 04:00PM EST
38.50 -0.17 (-0.44%)
After hours: 08:00PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 3.71B
Enterprise value 3.39B
Trailing P/E 75.82
Forward P/E 55.25
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.76
Price/book (mrq)7.19
Enterprise value/revenue 3.28
Enterprise value/EBITDA 63.00

Trading information

Stock price history

Beta (5Y monthly) 1.51
52-week change 324.38%
S&P500 52-week change 327.79%
52-week high 344.95
52-week low 329.44
50-day moving average 338.18
200-day moving average 336.69

Share statistics

Avg vol (3-month) 3698.6k
Avg vol (10-day) 3895.14k
Shares outstanding 595.84M
Implied shares outstanding 695.84M
Float 883.11M
% held by insiders 11.18%
% held by institutions 1101.20%
Shares short (31 Jan 2024) 46.22M
Short ratio (31 Jan 2024) 411.18
Short % of float (31 Jan 2024) 47.91%
Short % of shares outstanding (31 Jan 2024) 46.49%
Shares short (prior month 29 Dec 2023) 45.49M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023


Profit margin 5.03%
Operating margin (ttm)6.48%

Management effectiveness

Return on assets (ttm)5.22%
Return on equity (ttm)12.06%

Income statement

Revenue (ttm)1.03B
Revenue per share (ttm)10.95
Quarterly revenue growth (yoy)36.80%
Gross profit (ttm)N/A
Net income avi to common (ttm)51.98M
Diluted EPS (ttm)0.51
Quarterly earnings growth (yoy)20.30%

Balance sheet

Total cash (mrq)335.55M
Total cash per share (mrq)3.5
Total debt (mrq)19.49M
Total debt/equity (mrq)3.78%
Current ratio (mrq)3.16
Book value per share (mrq)5.38

Cash flow statement

Operating cash flow (ttm)202.67M
Levered free cash flow (ttm)174.97M